Treatment personalized

Patients should play an active role in their therapy. The development of a health care provider-patient partnership is vital to the success of any treatment plan. Goals for asthma treatment should be shared with the patient and family, and the patient and health care provider should jointly agree on the patient s personal treatment goals. 

Has the patient ever been on psychotropic medication before What are his or her attitudes about those experiences Have any family members or friends ever been on psychotropic medication If so, what medications did they take What are the patient s views about those experiences How educated is the patient How much information does the patient want about the effects—good and bad—of psychotropic medications It is important to inquire about any previous experiences the patient has had with psychotropic medication because these experiences will influence the initial response and attitude about taking medication. Previous experiences may include the patient s own personal treatment, another person s treatment, or something that the patient read or heard about on the Internet. 

Can we harness idiosyncratic differences in the wrapping patterns across patients to develop a personalized treatment ... 

Merck, Livin It. Tools—Personalized Treatment Planner. ... 

Kranzler HR, McKay JR (2012) Personalized treatment of alcohol dependence. Curr Psychiatry Rep 14 486-493... 

This will require a battery of diagnostic tools, which characterizes the patient in such a way that personalized treatment becomes a reality. Chemical biology will also make valuable contributions by dealing with the biological systems and supporting the development of new diagnostic tools. 

Tlie study of SNPs offers a way to specifically correlate genotype with (clinical) phenotype at the individual level, thus leading to a very personalized treatment or medicine. In order to achieve that goal, gene-specific sequencing and the cataloguing of SNPs plus correlation to the phenotype is necessary. 

Naioxone (Narcan) Surmountably blocks opioid receptors. Has no effect in narcotic-free persons. Treatment of narcotic overdose. Diagnostic agent (for evaluation of addiction) in methadone programs. To reduce postoperative respiratory depression. Induces narcotic withdrawal syndrome (appetite loss, muscle contraction, fever/chills, restlessness, cardiovascular and respiratory symptoms, nausea,vomiting, diarrhea.)... 

Table 1. A multifactorial approach to a personalized treatment of type 2 diabetes.

Personalized medicine simply means the prescription of specific therapeutics best suited for an individual. It is usually based on pharmacogenetic, pharmacoge-nomic, and pharmacoproteomic information but other individual variations in patients are also taken into consideration. In case of cancer, the variation in behavior of cancer of the same histological type from one patient to another is also taken into consideration. Nanodiagnostics have also improved diagnosis of cancer, which is an important basis of personalized treatment. 

One of the major challenges in personalized treatment is pharmacokinetic variability of drugs in patients. Real-time pharmacokinetic monitoring in patients will provide information for planning or designing further treatment plans and may also decrease the occurrence of drug-related adverse events. For the past few decades, the combination... 

The high prevalence of poor or insufficient sleep makes the phenomenon perceived as normative, and in spite of documented correlation between sleep and health, performance, cognition, memory, weight gain, and mood, people do not complain much about sleep issues. Many get sleeping pills on a regular or intermittent basis, and others self-medicate some try CBTI, but most suffer quietly. The availability of sleep assessment and personal treatment in the natural sleep environment and at a reasonable cost offers the opportunity to achieve an overall better life. 

K. C. Li, S. Guccione and M. D. Bednarski, Combined vascular targeted imaging and therapy a paradigm for personalized treatment. /. Cell Biochem. SuppL, 39, 65-71 (2002). 

---